Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lilly's Kisunla™ (donanemab) Approved in Great Britain for Mild Cognitive Impairment and Mild Dementia in Specific Alzheimer's Patients
Thursday, October 24, 2024Eli Lilly and Company has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency MHRA for donanemab a treatment targeting mild cognitive impairment and mild dementia caused by Alzheimers disease
Telix Announces New Drug Application for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Thursday, October 24, 2024Telix has announced that the US Food and Drug Administration FDA has accepted the New Drug Application NDA for TLXCDx Pixclara an imaging agent for glioma Gliomas are the most common primary brain tumours in the central nervous system particularly ch...
Alvotech and Teva Secure FDA Approval for New SELARSDI™ Presentation, Expanding Indications
Wednesday, October 23, 2024Alvotech and Teva Pharmaceuticals have announced that the US Food and Drug Administration FDA has approved SELARSDI ustekinumabaekn in a new mg mL mgmL solution for intravenous infusion
HELP Therapeutics Gains FDA Approval for HiCM-188 Cell Therapy to Treat End-stage Heart Failure
Wednesday, October 23, 2024HELP Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for Allogeneic Human iPSCderived cardiomyocytes HiCM
GSK Enters into Collaboration with Cambridge University on Kidney and Respiratory Disease
Tuesday, October 22, 2024GSK has announced a million investment in a fiveyear partnership with the University of Cambridge and Cambridge University Hospitals Chronic kidney disease impacts around million people worldwide often leading to endstage disease while chronic resp...
Adcentrx Therapeutics Receives FDA Clearance for ADRX-0405, a New ADC for Advanced Solid Tumours
Tuesday, October 22, 2024Adcentrx Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ADRX ADRX is an advanced antibodydrug conjugate ADC designed using a humanized IgG antibody that targets si...
Editas Enters into Collaboration with Genevant to Develop Gene Editing Therapies
Tuesday, October 22, 2024Editas Medicine and Genevant Sciences have entered into a collaboration and nonexclusive license agreement This partnership will combine Editas Medicines CRISPR Casa gene editing systems with Genevants lipid nanoparticle LNP technology to develop
Molecular Partners Signs Agreement with Orano Med to Co-Develop 212Pb-Based Radio-DARPin Therapeutics
Tuesday, October 22, 2024Molecular Partners has strengthened its codevelopment agreement with Orano Med DARPin Designed Ankyrin Repeat Protein therapeutics represent a novel class of customengineered protein drugs These therapeutics are designed to provide enhanced multifunc...
Everest Medicines Receives Taiwan TFDA Approval for NEFECON® to Treat IgA Nephropathy
Monday, October 21, 2024Everest Medicines has announced the approval of NEFECON by Taiwans Food and Drug Administration TFDA NEFECON is a patented delayedrelease oral formulation of budesonide
AFT Secures Late-Stage R&D Agreement for Novel Injectable Treatment
Monday, October 21, 2024AFT Pharmaceuticals has announced a partnership with two European companies to finalise the research and development of a novel injectable medicine containing a patented New Chemical Entity NCE
